Header cover image

South Korean (KOSPI) Clinical Research and Equipment Industry Analysis

UpdatedJan 31, 2023
DataAggregated Company Financials
Companies33
  • 7D0.5%
  • 3M-8.3%
  • 1Y5.0%
  • YTD-3.0%

The Clinical Research and Equipment industry is up 1.2% in the last week, with Samsung BiologicsLtd up 0.4%. In the last 12 months, the industry was up 5.7%. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 31 Jan 2023₩62.6t₩3.5t₩426.6b20.2x146.9x18x
Thu, 29 Dec 2022₩64.8t₩3.4t₩428.7b20.6x151.2x18.9x
Sat, 26 Nov 2022₩69.8t₩3.4t₩445.5b21.9x156.6x20.5x
Mon, 24 Oct 2022₩65.6t₩3.0t₩448.5b23.1x146.2x22x
Wed, 21 Sep 2022₩62.7t₩3.0t₩448.5b26.4x139.9x21x
Fri, 19 Aug 2022₩69.0t₩2.7t₩454.7b29.5x151.9x25.4x
Sun, 17 Jul 2022₩64.9t₩2.7t₩454.7b28.7x142.8x23.9x
Tue, 14 Jun 2022₩63.6t₩2.7t₩454.7b25.3x139.8x23.4x
Thu, 12 May 2022₩62.9t₩2.4t₩379.4b22.7x165.7x25.9x
Sat, 09 Apr 2022₩60.2t₩2.4t₩379.4b25x158.8x24.8x
Mon, 07 Mar 2022₩57.8t₩2.4t₩408.2b26x141.7x24.6x
Wed, 02 Feb 2022₩55.6t₩2.3t₩412.7b23.7x134.7x23.7x
Fri, 31 Dec 2021₩67.8t₩2.3t₩412.7b28.3x164.4x28.9x
Sun, 28 Nov 2021₩64.9t₩2.3t₩390.6b26.2x166x28x
Tue, 26 Oct 2021₩64.9t₩2.1t₩329.9b27.1x196.8x30.2x
Thu, 23 Sep 2021₩69.7t₩2.1t₩329.9b31.2x211.2x32.4x
Sat, 21 Aug 2021₩73.0t₩2.2t₩336.8b32.9x216.7x33x
Sat, 05 Jun 2021₩64.3t₩2.1t₩247.5b38.6x259.8x30.9x
Tue, 09 Mar 2021₩57.5t₩2.0t₩213.0b64.8x269.9x29x
Mon, 30 Nov 2020₩59.9t₩1.8t₩306.1b59.1x195.6x32.4x
Thu, 03 Sep 2020₩59.4t₩1.7t₩273.1b77.8x217.6x36x
Sun, 07 Jun 2020₩45.7t₩1.4t₩209.9b76.6x217.7x32.8x
Sat, 29 Feb 2020₩34.0t₩1.2t₩177.8b57x191.1x28x
Price to Earnings Ratio

198.1x


Total Market Cap: ₩35.2tTotal Earnings: ₩177.8bTotal Revenue: ₩1.2tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Clinical Research and Equipment Industry Price to Earnings3Y Average 189.5x202120222023
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 148x which is lower than its 3-year average PE of 189x.
  • The 3-year average PS ratio of 27.8x is higher than the industry's current PS ratio of 18.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 34% per year over the last three years.
  • Revenues for these companies have grown 42% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does South Korean Clinical Research and Equipment compare with similar industries?

KR Market2.46%
Healthcare0.63%
Life Sciences0.46%
Clinical Research and Equipment0.46%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A268600 Cellivery Therapeutics₩13.06k37.0%
+₩128.4b
-18.2%PS22.3x
A087010 Peptron₩8.32k9.5%
+₩14.9b
-6.0%PS29.5x
A220100 FutureChemLtd₩9.80k5.0%
+₩10.4b
-20.4%PS18.5x
A038290 Macrogen₩21.50k4.9%
+₩8.3b
-12.2%PE95.6x
A245620 Eone Diagnomics Genome Center₩1.87k3.9%
+₩5.9b
-56.0%PS1.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A207940

₩793,000.00

Samsung BiologicsLtd

7D

-0.9%

1Y

7.3%

A237690

₩81,300.00

ST PharmLtd

7D

-0.9%

1Y

-22.9%

A141080

₩36,750.00

LegoChem Biosciences

7D

-0.7%

1Y

-18.1%

A278650

₩4,835.00

KNOTUSLtd

7D

1.4%

1Y

70.6%

A038290

₩21,500.00

Macrogen

7D

4.9%

1Y

-12.2%

A087010

₩8,320.00

Peptron

7D

9.5%

1Y

-6.0%

A114450

₩4,750.00

KPX Lifescience.Co.Ltd

7D

-5.8%

1Y

-28.9%

A220100

₩9,800.00

FutureChemLtd

7D

5.0%

1Y

-20.4%

A216400

₩7,120.00

Invites Biocore

7D

-2.7%

1Y

-28.4%

A217950

₩25,650.00

PHARMARESEARCH BIO

7D

-5.4%

1Y

-15.5%

A331920

₩6,050.00

Celemics

7D

-0.7%

1Y

-46.0%